Quatro and Kemble merge:
This article was originally published in Clinica
UK companies Quatro Biosystems and Kemble Instruments have merged to form Zenyx Scientific. The merger combines Quatro's expertise in novel image analysis with Kemble's sample processor technology. Zenyx will compete at global level in the market for immunohaematology, immunoassay and high throughput screening, says chief executive Peter McCulloch, formerly of Quatro.